A clinical study on karisalankanni chooranam in patients with anaemia

AN OPEN CLINICAL STUDY ON PAANDU NOI (IRON DEFICIENCY ANEMIA) IN CHILDREN WITH THE EVALUATION OF SIDDHA TRIAL DRUG KARISALANKANNI CHOORANAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015423

Enrollment

Registered

2018-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Health Condition 2: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Karisalankanni choornam: 200 to 500 mg twice a day Adjuvant honey for 28 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Angular stomatitis Hb level 7 12gm Pallor of skin,mucous membrane,nail bed,conjunctiva Lack of concentration Poor school performance Fatigue Constipation

Exclusion criteria

Exclusion criteria: Hb less than 7 gram Known H/O metabolic disorder Known H/O hemolytic anaemia Patient with any other serious illness

Design outcomes

Primary

Measure	Time frame
Primary outcome is assessed by reduction of the clinical symptoms before and after treatmentTimepoint: Nil	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr k Karpagavalli

Government siddha medical college

dr.shanmugapriyaa.km@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026